Precision-based assessment before and during treatment may identify responders and non-responders earlier
If you have a history of certain cancers (such as medullary thyroid cancer) or a rare condition called multiple endocrine neoplasia syndrome type 2, these medications are not recommended for you
When it is finally released, its availability must be more strictly controlled than semaglutide to avoid similar life-threatening usage. Dr Marie Spreckley, of the MRC epidemiology unit at the University of Cambridge, said: Higher discontinuation due to adverse events, particularly gastrointestinal symptoms, is a key consideration and may have implications for tolerability and adherence in real-world settings. She added that because the trial lasted only one year, longer-term safety, cardiovascular outcomes and sustained effectiveness remained important unanswered questions
Such evidence, however, is supported by many relevant pre-clinical or mechanistic studies highlighting the neuroprotective and anti-inflammatory activity of these medications
No, not in the formal pharmacological sense
Treatment with ACTH also improves catalase activity 19 (Figure 1)